Farnesyl diphosphate synthase attenuates paclitaxel-induced apoptotic cell death in human glioblastoma U87MG cells

Neuroscience Letters

Volumn 474, Issue 2, 2010, Pages 115-120

  Woo, Im Sun ^a   Eun, So Young ^a   Kim, Hyo Jung ^a   Kang, Eun Sil ^a   Kim, Hye Jung ^a   Lee, Jae Heun ^a   Chang, Ki Churl ^a   Kim, Jin Hoi ^b   Hong, Soon Chan ^c   Seo, Han Geuk ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Konkuk University   (South Korea)

^c Gyeongsang National University   (South Korea)

Author keywords

Apoptosis; Bax; Farnesyl diphosphate synthase; Glioblastoma; Paclitaxel

Indexed keywords

CYTOCHROME C; FARNESYL DIPHOSPHATE; GERANYLTRANSFERASE; MEVALONATE KINASE; PACLITAXEL; PAMIDRONIC ACID; PROTEIN BAX; PROTEIN BCL XL; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; ATTENUATION; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL VIABILITY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DIPHOSPHONATES; DRUG SYNERGISM; FLOW CYTOMETRY; GERANYLTRANSTRANSFERASE; GLIOBLASTOMA; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MEVALONIC ACID; PACLITAXEL; POLYISOPRENYL PHOSPHATES; SESQUITERPENES; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77951203561     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.03.021     Document Type: Article

References (18)

1. Boldt S., Weidle U.H., Kolch W. The role of MAPK pathways in the action of chemotherapeutic. Carcinogenesis 2002, 23:1831-1838.
2. Brandsma D., Stalpers L., Taal W., Sminia P., van den Bent M.J. Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas. Lancet Oncol. 2008, 9:453-461.
3. Eun S.Y., Woo I.S., Jang H.S., Jin H., Kim M.Y., Kim H.J., Lee J.H., Chang K.C., Kim J.H., Seo H.G. Identification of cytochrome c oxidase subunit 6A1 as a suppressor of Bax-induced cell death by yeast-based functional screening. Biochem. Biophys. Res. Commun. 2008, 373:58-63.
4. Giannakakou P., Robey R., Fojo T., Blagosklonny M.V. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity. Oncogene 2001, 20:3806-3813.
5. Jiang F., Yang L., Cai X., Cyriac J., Shechter I., Wang Z. Farnesyl diphosphate synthase is abundantly expressed and regulated by androgen in rat prostatic epithelial cells. J. Steroid Biochem. Mol. Biol. 2001, 78:123-130.
6. Kang E.S., Woo I.S., Kim H.J., Eun S.Y., Paek K.S., Kim H.J., Chang K.C., Lee J.H., Lee H.T., Kim J.H., Nishinaka T., Yabe-Nishimura C., Seo H.G. Up-regulation of aldose reductase expression mediated by phosphatidylinositol 3-kinase/Akt and Nrf2 is involved in the protective effect of curcumin against oxidative damage. Free Radic. Biol. Med. 2007, 43:535-545.
7. Kim H.J., Kim M.Y., Jin H., Kim H.J., Kang S.S., Kim H.J., Lee J.H., Chang K.C., Hwang J.Y., Yabe-Nishimura C., Kim J.H., Seo H.G. Peroxisome proliferator-activated receptor β regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-β1/Smad3. Circ. Res. 2009, 105:16-24.
8. McTaggart S.J. Isoprenylated proteins. Cell Mol. Life Sci. 2006, 63:255-267.
9. Mo H., Elson C.E. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp. Biol. Med. 2004, 229:567-585.
10. Nicholson D.W. From bench to clinic with apoptosis-based therapeutic agents. Nature 2000, 407:810-816.
11. Notarnicola M., Messa C., Cavallini A., Bifulco M., Tecce M.F., Eletto D., Leo A.D., Montemurro S., Laezza C., Caruso M.G. Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. Oncology 2004, 67:351-358.
12. Riebeling C., Forsea A.M., Raisova M., Orfanos C.E., Geilen C.C. The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro. Br. J. Cancer 2002, 87:366-371.
13. Schor N.F. Pharmacotherapy for adults with tumors of the central nervous system. Pharmacol. Ther. 2009, 121:253-264.
14. Senaratne S.G., Pirianov G., Mansi J.L., Arnett T.R., Colston K.W. Bisphosphonates induce apoptosis in human breast cancer cell lines. Br. J. Cancer 2000, 82:1459-1468.
15. Szkopińska A., Płochocka D. Farnesyl diphosphate synthase; regulation of product specificity. Acta Biochim. Pol. 2005, 52:45-55.
16. Veenman L., Shandalov Y., Gavish M. VDAC activation by the 18kDa translator protein (TSPO), implications for apoptosis. J. Bioenerg. Biomembr. 2008, 40:199-205.
17. Vousden K.H., Lu X. Live or die: the cell's response to p53. Nat. Rev. Cancer 2002, 2:594-604.
18. Wada A., Fukui K., Sawai Y., Imanoka K., Kiso S., Tamura S., Shimomura I., Hayashi N. Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma. J. Hepatol. 2006, 44:142-150.